Skip to ContentSkip to Navigation
How to find us drs. J.M. van Rooijen


Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Optimizing systemic therapy in metastatic breast cancer: implementation in daily practice and exploration of new drug targets

Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: A population-based study focusing on the elderly

Immunotherapeutic options on the horizon in breast cancer treatment

Read more